QIPT vs. VMD, PRN, PTQ, HTL, PHM, HSM, TLT, VPT, EXE, and GUD
Should you be buying Quipt Home Medical stock or one of its competitors? The main competitors of Quipt Home Medical include Viemed Healthcare (VMD), Profound Medical (PRN), Protech Home Medical (PTQ), Hamilton Thorne (HTL), Protech Home Medical (PHM), Helius Medical Technologies (HSM), Theralase Technologies (TLT), VentriPoint Diagnostics (VPT), Extendicare (EXE), and Knight Therapeutics (GUD). These companies are all part of the "medical" sector.
Quipt Home Medical (TSE:QIPT) and Viemed Healthcare (TSE:VMD) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, institutional ownership, earnings, analyst recommendations, community ranking, valuation and risk.
Quipt Home Medical has a beta of 1.06, meaning that its share price is 6% more volatile than the S&P 500. Comparatively, Viemed Healthcare has a beta of 1.19, meaning that its share price is 19% more volatile than the S&P 500.
Viemed Healthcare has lower revenue, but higher earnings than Quipt Home Medical. Quipt Home Medical is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.
Quipt Home Medical received 11 more outperform votes than Viemed Healthcare when rated by MarketBeat users. However, 100.00% of users gave Viemed Healthcare an outperform vote while only 81.25% of users gave Quipt Home Medical an outperform vote.
In the previous week, Viemed Healthcare had 1 more articles in the media than Quipt Home Medical. MarketBeat recorded 1 mentions for Viemed Healthcare and 0 mentions for Quipt Home Medical. Viemed Healthcare's average media sentiment score of 0.67 beat Quipt Home Medical's score of 0.00 indicating that Viemed Healthcare is being referred to more favorably in the news media.
Viemed Healthcare has a net margin of 5.42% compared to Quipt Home Medical's net margin of -1.79%. Viemed Healthcare's return on equity of 9.08% beat Quipt Home Medical's return on equity.
46.8% of Quipt Home Medical shares are owned by institutional investors. Comparatively, 66.0% of Viemed Healthcare shares are owned by institutional investors. 3.8% of Quipt Home Medical shares are owned by company insiders. Comparatively, 2.5% of Viemed Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Quipt Home Medical presently has a consensus price target of C$10.87, suggesting a potential upside of 136.82%.
Summary
Viemed Healthcare beats Quipt Home Medical on 11 of the 16 factors compared between the two stocks.
Get Quipt Home Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for QIPT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding QIPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Quipt Home Medical Competitors List
Related Companies and Tools
